Complimentary U.S. shipping on orders over $250 American-manufactured Independently verified Documentation on request
01 Catalog GLP-3 (10MG) triple incretin analog research peptide vial — BioFusion Aminos
Catalog

Reta GLP-3 (10MG)

GLP-3 (10MG) lyophilized peptide for laboratory research. HPLC-verified ≥99% purity, batch-specific COA, American-manufactured. Ships 24h.

$170.00


Proceed to Checkout

Research Use Only. Not for human or veterinary use.

American-manufactured Ships 24-48h Research Use Only
About the Standard

Documented reference chemistry.

GLP-3 — the triple-incretin (GLP-1 + GIP + glucagon receptor) research analog from the retatrutide class — supplied by BioFusion as a vacuum-sealed lyophilized vial of 10mg for triple-receptor metabolic-pathway research.

Research context

GLP-3 in the BioFusion catalog refers to the retatrutide-class triple-incretin research analog, the next-generation incretin-research compound after the dual-incretin tirzepatide class. The triple-receptor agonist profile (GLP-1R + GIPR + GcgR) makes it a frequent inclusion in comparative-binding-affinity research and metabolic-pathway-mapping studies. The incretin chemistry primer walks through the structural basis of single- vs dual- vs triple-class incretin analogs.

Synthesis & documentation

Produced by solid-phase peptide synthesis using Fmoc protecting-group strategy in a U.S.-based ISO 9001:2008 facility. Each lot is verified for identity (LC-MS), purity (reverse-phase HPLC-UV ≥99.0%), moisture (Karl Fischer), and counter-ion (ion chromatography). The signed Certificate of Analysis ships with every order. Compare with our GLP-1 single-incretin reference and GLP-2 dual-incretin reference for cross-class research panels.

Storage & handling

Lyophilized GLP-3 is stable at −20 °C for the printed shelf life. After reconstitution, the standard 14-day-at-2-8 °C reference window applies; avoid freeze-thaw cycling. The BioFusion reconstitution calculator handles working-concentration math for any intended protocol.

Why BioFusion

Triple-incretin analogs are exceptionally difficult to synthesize correctly — sequence length, modification placement, and side-chain conjugation make low-purity by-products common. BioFusion verifies LC-MS molecular weight against the canonical retatrutide-class reference and publishes synthesis-date plus HPLC-purity on the batch transparency ledger. Bulk discounts trigger at three+ vials; members save 25% on every order plus complimentary U.S. shipping for 365 days.

For research and laboratory use only. This product is not a drug, food, or cosmetic, and is not intended for diagnostic, therapeutic, or in vivo human use.

From the Same Class

Related reference standards.

View the catalog →